(Q37211812)

19 August 2017

Identification of high-risk factors as indicators for adjuvant therapy in stage II colon cancer patients treated at a single institution (English)

1 reference

19 August 2017

1 reference

Keizo Yamaguchi

1

1 reference

19 August 2017

Yutaka Ogata

series ordinal

2

1 reference

19 August 2017

Yoshito Akagi

series ordinal

3

1 reference

19 August 2017

Kazuo Shirouzu

series ordinal

4

1 reference

19 August 2017

1 July 2013

1 reference

19 August 2017

1 reference

19 August 2017

6

1 reference

19 August 2017

3

1 reference

19 August 2017

659-666

1 reference

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer.

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789105

Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789105

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789105

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789105

DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789105

The use of cancer registry data to study preoperative carcinoembryonic antigen level as an indicator of survival in colorectal cancer

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789105

Carcinoma obstruction of the proximal colon cancer and long-term prognosis--obstruction is a predictor of worse outcome in TNM stage II tumor.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789105

Identifying stage B colorectal cancer patients at high risk of tumor recurrence and death

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789105

Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789105

Metastatic potential of human colon cancer cell lines: relationship to cellular differentiation and carcinoembryonic antigen production

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789105

Differences in clinicopathological characteristics of colorectal cancer between younger and elderly patients: an analysis of 322 patients from a single institution

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789105

High-risk stage II colon cancer after curative resection.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789105

Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789105

Colon cancer: ESMO clinical recommendations for diagnosis, adjuvant treatment and follow-up

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789105

Identification of patients with high-risk lymph node-negative colorectal cancer and potential benefit from adjuvant chemotherapy.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789105

Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789105

Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789105

Identification of patients with high-risk stage II colon cancer for adjuvant therapy

4 December 2018

1 reference

12 December 2020

Gender differences in long-term survival of patients with colorectal cancer

1 reference

12 December 2020

Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population

1 reference

12 December 2020

Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer

1 reference

12 December 2020

Defining a high-risk subgroup with colon cancer stages I and II for possible adjuvant therapy

1 reference

12 December 2020

Prognostic significance of preoperative bowel obstruction in stage III colorectal cancer

1 reference

12 December 2020

The effect of age and gender on outcome after treatment for colon carcinoma. A population-based study in the Uppsala and Stockholm region

1 reference

12 December 2020

Identifying patients with T3-T4 node-negative colon cancer at high risk of recurrence

1 reference

12 December 2020

Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators

1 reference

12 December 2020

Male gender adversely affects survival following surgery for colorectal cancer

1 reference

12 December 2020

Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer

1 reference

12 December 2020

Carcinomatous lymphatic permeation. Prognostic significance in patients with rectal carcinoma--a long term prospective study

1 reference

12 December 2020

The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP (National Surgical Adjuvant Breast and Bowel Project) clinical trials

1 reference

12 December 2020

A prospective clinicopathologic study of venous invasion in colorectal cancer

1 reference

12 December 2020

Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study

1 reference

12 December 2020

Identifiers

DOI

10.3892/OL.2013.1433

1 reference

release_fai7qqr35vglzbbhmxlvk4qkmi

19 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fai7qqr35vglzbbhmxlvk4qkmi

24 November 2022

mapped directly with Wikidata item

1 reference

19 August 2017

PubMed publication ID

24137386

1 reference